sulfamethoxypyridazine has been researched along with Jaundice in 3 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Jaundice: A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
STOCCHI, F | 1 |
MASTRILLI, B | 1 |
DUNN, PM | 1 |
Babior, BM | 1 |
Davidson, CS | 1 |
3 other studies available for sulfamethoxypyridazine and Jaundice
Article | Year |
---|---|
[Contribution to the study of jaundice caused by intrahepatic cholestasis of drug origin: forms of chlorpropamide and sulfamethoxypyridazine].
Topics: Chlorpropamide; Cholestasis, Intrahepatic; Humans; Hypoglycemic Agents; Jaundice; Sulfamethoxypyrida | 1962 |
THE POSSIBLE RELATIONSHIP BETWEEN THE MATERNAL ADMINISTRATION OF SULPHAMETHOXYPYRIDAZINE AND HYPERBILIRUBINAEMIA IN THE NEWBORN.
Topics: Female; Humans; Hyperbilirubinemia; Infant; Infant, Newborn; Jaundice; Jaundice, Neonatal; Maternal- | 1964 |
Hepatitis: drug or viral?
Topics: Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Halothane; Hepatitis A; Humans; Ipr | 1966 |